Allopurinol NEW
| Price | $65 |
| Package | 10g |
| Supply Ability: | 10g |
| Update Time: | 2026-07-14 |
Product Details
| Product Name: Allopurinol | CAS No.: 315-30-0 |
| Purity: 99.36% | Supply Ability: 10g |
| Release date: 2026/07/14 |
Product Introduction
Bioactivity
| Name | Allopurinol |
| Description | Allopurinol (Zyloric) is a Xanthine Oxidase Inhibitor. The mechanism of action of allopurinol is as a Xanthine Oxidase Inhibitor. |
| In vitro | 10 mM Allopurinol inhibited the activity of oxygen xanthine oxidase produced by hypoxia-reoxygenation injury.Allopurinol reduced intracellular Ca2+ concentration by enhancing xanthine oxidase activity.Allopurinol reversed the increase in xanthine oxidase activity in neonatal rat hearts with ischemia-reperfusion injury. |
| In vivo | 10 mM Allopurinol inhibited the activity of oxygen xanthine oxidase produced by hypoxia-reoxygenation injury.Allopurinol reduced intracellular Ca2+ concentration by enhancing xanthine oxidase activity.Allopurinol reversed the increase in xanthine oxidase activity in neonatal rat hearts with ischemia-reperfusion injury. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | Ethanol : 3 mg/mL (22.04 mM), Sonication is recommended. H2O : Insoluble 10% DMSO+40% PEG300+5% Tween-80+45% Saline : 0.5 mg/mL (3.67 mM), Sonication is recommended. DMSO : 16.4 mg/mL (120.49 mM), Sonication is recommended. |
| Keywords | XO | XanthineOxidase | Xanthine Oxidase | orally active | Inhibitor | inhibit | hyperuricemia | HUVEC cells | HIF-2α | HIF-1α | gout | anti-nociception | anti-leishmanial | anti-depressant | Allopurinol |
| Inhibitors Related | Ethoxyquin | Kaolin | Imeglimin hydrochloride | L-Ascorbic acid | Ethyl linoleate | Magnesium acetate tetrahydrate | Inosine | L-Cystine | Dimethyl itaconate | Copper Sulfate Pentahydrate | L-Ascorbic acid sodium salt | Dimethyl phthalate |
| Related Compound Libraries | Bioactive Compound Library | EMA Approved Drug Library | Anti-Cancer Clinical Compound Library | Anti-Viral Compound Library | Drug Repurposing Compound Library | Inhibitor Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Drug Library |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries， 10000+ Noval Small Molecucles，16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP6Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2026-07-20 | ||
| $100.00 |
VIP2Y
|
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
|
2026-07-16 | |
| $65.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-07-14 | |
|
VIP2Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2026-07-13 | ||
| $65.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-07-13 | |
|
VIP6Y
|
Sinoway Industrial co., ltd.
|
2026-07-02 | ||
| $10.00 |
Hebei Chuanghai Biotechnology Co., Ltd
|
2026-03-20 | ||
| $12.00 |
Hebei Yanxi Chemical Co., Ltd.
|
2025-06-20 | ||
|
VIP3Y
|
Shaanxi TNJONE Pharmaceutical Co., Ltd
|
2025-04-02 | ||
| $100.00 |
Hebei Fengqiang Trading Co., LTD
|
2023-08-31 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, Massachusetts, USA
INQUIRY